Compare with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES NATCO PHARMA ZIM LABORATORIES/
NATCO PHARMA
 
P/E (TTM) x 30.7 59.8 51.3% View Chart
P/BV x 1.2 3.7 32.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ZIM LABORATORIES   NATCO PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
NATCO PHARMA
Mar-21
ZIM LABORATORIES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs131995 13.2%   
Low Rs53492 10.7%   
Sales per share (Unadj.) Rs189.2112.5 168.1%  
Earnings per share (Unadj.) Rs4.524.3 18.6%  
Cash flow per share (Unadj.) Rs14.230.7 46.4%  
Dividends per share (Unadj.) Rs05.25 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs99.0225.1 44.0%  
Shares outstanding (eoy) m16.24182.34 8.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.56.6 7.4%   
Avg P/E ratio x20.530.6 66.7%  
P/CF ratio (eoy) x6.524.2 26.7%  
Price / Book Value ratio x0.93.3 28.2%  
Dividend payout %021.6 0.0%   
Avg Mkt Cap Rs m1,497135,564 1.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3584,149 8.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,07320,521 15.0%  
Other income Rs m231,036 2.3%   
Total revenues Rs m3,09621,557 14.4%   
Gross profit Rs m3466,062 5.7%  
Depreciation Rs m1581,169 13.5%   
Interest Rs m109133 81.9%   
Profit before tax Rs m1025,796 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m291,372 2.1%   
Profit after tax Rs m734,424 1.7%  
Gross profit margin %11.329.5 38.1%  
Effective tax rate %28.523.7 120.3%   
Net profit margin %2.421.6 11.0%  
BALANCE SHEET DATA
Current assets Rs m1,91823,373 8.2%   
Current liabilities Rs m1,4205,256 27.0%   
Net working cap to sales %16.288.3 18.3%  
Current ratio x1.44.4 30.4%  
Inventory Days Days1663 25.1%  
Debtors Days Days85873 1,168.7%  
Net fixed assets Rs m1,30424,546 5.3%   
Share capital Rs m162365 44.5%   
"Free" reserves Rs m1,44540,676 3.6%   
Net worth Rs m1,60841,041 3.9%   
Long term debt Rs m2189 2,425.4%   
Total assets Rs m3,22247,919 6.7%  
Interest coverage x1.944.6 4.3%   
Debt to equity ratio x0.10 61,923.9%  
Sales to assets ratio x1.00.4 222.7%   
Return on assets %5.79.5 59.5%  
Return on equity %4.610.8 42.2%  
Return on capital %11.614.4 80.1%  
Exports to sales %67.40-   
Imports to sales %4.110.9 38.2%   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m1272,231 5.7%   
Fx inflow Rs m2,14011,194 19.1%   
Fx outflow Rs m1272,231 5.7%   
Net fx Rs m2,0128,963 22.5%   
CASH FLOW
From Operations Rs m3192,988 10.7%  
From Investments Rs m-59-1,033 5.7%  
From Financial Activity Rs m-260-1,857 14.0%  
Net Cashflow Rs m-160 -1.2%  

Share Holding

Indian Promoters % 33.3 48.9 68.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 30.3 -  
FIIs % 0.0 12.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 51.1 130.5%  
Shareholders   4,610 88,439 5.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   TYCHE INDUSTRIES  STRIDES PHARMA SCIENCE  KERALA AYURV  TORRENT PHARMA  PFIZER  



Today's Market

Sensex Trades Higher, Nifty Above 17,250; Power Grid, IOC & Titan Among Top Gainers(10:30 am)

Asian share markets fell in early trade today hit by worries about the Omicron coronavirus variant and a hawkish tilt at the US Federal Reserve.

Related Views on News

NATCO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 18, 2021 | Updated on Oct 18, 2021

Here's an analysis of the annual report of NATCO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NATCO PHARMA. Also includes updates on the valuation of NATCO PHARMA.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Dec 2, 2021 02:29 PM

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES - WINDLAS BIOTECH COMPARISON

COMPARE ZIM LABORATORIES WITH

MARKET STATS